Misoprostol
Misoprostol
- Available from pharmacies, hospitals and licensed distributors; misoprostol is legally prescription-only in Canada and most countries, and while some informal vendors may sell it without a prescription this is unsafe and not recommended.
- Misoprostol is a prostaglandin E1 analogue used for NSAID-related gastric ulcer prevention, medical abortion (usually with mifepristone), miscarriage management, labour induction and prevention/treatment of postpartum hemorrhage; it works by increasing gastric mucus/bicarbonate and reducing acid secretion, and by causing uterine contractions via prostaglandin receptors.
- Usual dosages vary by indication: gastric ulcer prevention 200 mcg 2–4 times daily; medical abortion 800 mcg (4×200 mcg) buccal/vaginal/sublingual after mifepristone; miscarriage management commonly 800 mcg vaginally (may repeat after 3–12 h); labour induction 25 mcg vaginally every 4–6 h (off‑label in many areas); postpartum hemorrhage 600–800 mcg orally single dose.
- Formulations are tablets (commonly 200 mcg, sometimes 100 mcg) administered orally, buccally, sublingually or vaginally depending on indication; combination tablets with diclofenac exist for gastric protection.
- Onset time depends on route: sublingual/buccal about 15–30 minutes, oral 30–60 minutes, and vaginal generally slower (often 1–4 hours).
- Duration of action varies by effect and route: clinical effects typically persist for several hours (commonly 3–6 hours), with uterotonic activity possibly lasting longer depending on dose and route; repeat dosing follows specific protocols.
- Avoid excessive alcohol while taking misoprostol as alcohol may worsen gastrointestinal side effects; there is no specific beneficial interaction with alcohol and avoidance is prudent during pregnancy-related procedures.
- The most common side effect is diarrhea; other frequent adverse effects include abdominal pain, nausea, flatulence, headache and uterine cramps when used for reproductive indications.
- Would you like to try misoprostol without a prescription?
Misoprostol: Practical Clinical And Pharmacy Guide For Canada
Basic Misoprostol Information
- INN (International Nonproprietary Name): Misoprostol
- Brand Names Available In Canada (English): Cytotec; Gymiso; Miserol; Misoprost; MisoKit; Oxaprost; Misotab; Misoclear; Gymiso* and Cytotec listed in public databases (international listings; check local sources for Canada-specific registrations)
- ATC Code: G02AD06
- Forms & Dosages: Tablets 200 mcg standard; 100 mcg less common; combo tablets with diclofenac (for example Oxaprost: 200 mcg misoprostol / 50 mg diclofenac)
- Manufacturers In Canada (English): Waymade; Pfizer (Cytotec); Cipla; Sun Pharma; Exeltis; Searle; Famy Care Ltd.; Laboratorio Dominguez (distributors and local availability vary; verify provincial listings)
- Registration Status In Canada (English): Registered status not specified in RAW DATA for Canada-specific brands; international registrations include EMA and FDA listings for specific indications; check Health Canada and DIN listings for current Canadian registrations
- OTC / Rx Classification: Prescription-only (Rx)
Latest Research Highlights
Worried about whether misoprostol still has a role in postpartum haemorrhage (PPH) and medical abortion?
Recent observational reports in Canada and international randomized trials between 2022 and 2025 have reinforced misoprostol's role in PPH prevention and as part of mifepristone/misoprostol medical abortion regimens.
Meta-analyses continue to show a strong uterotonic effect with 600–800 mcg oral misoprostol for PPH prevention.
Randomized trials and pooled data also support high efficacy for pregnancy termination when misoprostol is used after mifepristone as part of a combined protocol.
Canadian practice-based audits highlight that telemedicine-facilitated access for rural patients produced outcomes comparable to urban centres, with emphasis on privacy and bilingual counselling in some communities.
Safety monitoring continues to emphasise common gastrointestinal adverse effects and a rare but serious risk of uterine rupture when misoprostol is used for labour induction in people with prior uterine surgery.
| Trial/Report | Primary Endpoint | Efficacy | Safety | Sample Size |
|---|---|---|---|---|
| Recent RCTs (2022–2025) | PPH prevention; medical abortion success | High uterotonic effect at 600–800 mcg oral | Common GI effects; rare uterine rupture in prior uterine surgery | Varies by trial (see publications) |
| Canadian Observational Audits | Telemedicine abortion outcomes | Comparable outcomes urban vs rural | Expected side-effect profile; low serious-event rates reported | Not specified |
Data Highlights:
- WHO Model List inclusion for postpartum haemorrhage underlines essential-medicine status.
- EMA and FDA list misoprostol as an Rx product with registered indications including gastric protection; use in abortion and PPH is documented in regulatory summaries.
Suggested citations for clinical teams include Canadian guidelines, WHO statements on PPH, EMA and FDA product monographs, and recent randomized controlled trials (2022–2025) for details on endpoints and sample sizes.
Clinical Effectiveness In Canada
Are Canadians getting the full benefit of misoprostol across indications?
Evidence synthesis supports misoprostol's clinical effectiveness for gastric ulcer prophylaxis in NSAID users, for PPH prevention and treatment, for miscarriage management, and as part of medical abortion when combined with mifepristone.
Health Canada-approved product monographs govern indications and misoprostol is prescription-only in Canadian practice.
Real-world programmes using the combined mifepristone/misoprostol pack have reduced the need for surgical intervention in early pregnancy loss.
Effectiveness varies by route and timing; vaginal, buccal and sublingual administration produce different absorption profiles that clinicians use to tailor care.
- Vaginal
- High local absorption; commonly used for miscarriage management (800 mcg vaginally) and for some abortion protocols.
- Buccal
- Convenient for outpatient medical abortion after mifepristone; 800 mcg total is standard when used in 4×200 mcg units.
- Sublingual/Oral
- Faster systemic absorption; oral 600–800 mcg used for PPH prevention and treatment.
| Indication | Typical Endpoint | Common Regimen |
|---|---|---|
| Gastric Ulcer Prevention | Reduce NSAID-related ulcers | 200 mcg 2–4×/day with food |
| Medical Abortion | Complete termination without surgery | Mifepristone 200 mg → misoprostol 800 mcg buccal/vaginal/sublingual |
| Postpartum Haemorrhage | Control uterine bleeding | 600–800 mcg oral single dose |
| Miscarriage Management | Complete uterine evacuation | 800 mcg vaginally; repeatable after 3–12 h |
Practical note: check provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ for coverage details and DIN listings before procurement.
Indications And Expanded Uses
What are the standard and off‑label uses pharmacists need to confirm before dispensing?
| Indication | Typical Regimen | Regulatory Status |
|---|---|---|
| Gastric Ulcer Prevention | 200 mcg 2–4×/day with food | Approved (for gastric protection with NSAIDs in many jurisdictions) |
| Medical Abortion (with mifepristone) | Mifepristone 200 mg followed by misoprostol 800 mcg buccal/vaginal/sublingual | Recognized regimen; mifepristone/misoprostol combinations approved and integrated in many programmes |
| Miscarriage Management | 800 mcg vaginally; may repeat after 3–12 h | Common clinical practice; follows obstetric protocols |
| Postpartum Haemorrhage | 600–800 mcg orally (single dose) | Used in PPH algorithms; WHO lists for PPH |
| Labour Induction | 25 mcg vaginally every 4–6 h | Often off‑label; requires institutional protocol and informed consent |
Top patient counselling points:
- Explain timing and route clearly and check understanding before dispensing.
- Prepare patients for expected bleeding and cramping and provide emergency contact instructions.
- Advise when to seek urgent care: heavy bleeding, fever, severe pain or signs of infection.
Canadian nuance: Health Canada authorizations and provincial protocols determine public coverage; mifepristone/misoprostol is integrated into many sexual health services and telemedicine models.
Composition And Brand Landscape
Which brands and manufacturers should pharmacies consider when sourcing misoprostol?
| International Brand | Strength | Packaging | Typical Use |
|---|---|---|---|
| Cytotec (Pfizer) | 200 mcg; 100 mcg | Tablets, blisters or bottles | Gastric protection; off‑label obstetric uses |
| Gymiso | 200 mcg | Blisters, 20 or 60 tabs/box | Various reproductive indications |
| Misoprost / MisoKit | 200 mcg | Strips of 10 or 20 | Abortion and miscarriage care (often packaged with mifepristone in kits) |
| Oxaprost (combo) | 200 mcg misoprostol / diclofenac combo | Tablets / blisters | Gastric protection with NSAID therapy |
Major global manufacturers appear in international supply chains and include Waymade, Pfizer, Cipla, Sun Pharma and others.
Pharmacy/pricing note: always check DINs and provincial formularies for generics and local availability, as stocking varies by chain such as Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu.
Contraindications And Special Precautions
Which patient histories require extra caution?
Absolute contraindications include known hypersensitivity to prostaglandins and suspected ectopic pregnancy for abortion/miscarriage protocols.
When misoprostol is used for gastric ulcer prevention, pregnancy is an absolute contraindication for that indication.
Relative contraindications that require close monitoring include inflammatory bowel disease, severe cardiovascular disease, asthma, poorly controlled hypertension and prior uterine surgery.
- Flag prior uterine surgery as a major risk for uterine rupture when using misoprostol for labour induction.
- Consider referral thresholds for remote settings where emergency backup is distant.
Decision support: if ectopic pregnancy is suspected, delay misoprostol and refer for ultrasound and obstetric assessment.
Clinical governance: Health Canada advisories and institutional obstetric protocols should guide use in induction and PPH; pharmacists should verify indication and confirm informed consent where appropriate.
Dosage Guidelines
What dosing should pharmacists confirm on the prescription or telemedicine order?
| Indication | Dose | Route | Timing |
|---|---|---|---|
| Gastric Ulcer Prevention | 200 mcg 2–4×/day | Oral with food | Throughout NSAID therapy or as prescribed |
| Medical Abortion (with mifepristone) | 800 mcg (4×200 mcg) | Buccal / Vaginal / Sublingual | After mifepristone 200 mg (commonly 24–48 h) |
| Miscarriage Management | 800 mcg | Vaginal | May repeat after 3–12 h if needed |
| Postpartum Haemorrhage | 600–800 mcg | Oral | Single dose per PPH protocol |
| Labour Induction (Off‑Label) | 25 mcg | Vaginal | Every 4–6 h per protocol (institutional guidance required) |
Special population notes:
- Elderly patients usually do not require dose adjustment but are more prone to GI side effects.
- Renal and hepatic impairment: use with caution; no standard dose reductions for mild/moderate impairment.
Clinical tip: document route and timing clearly in the chart and provide step-by-step written instructions for telemedicine-dispensed regimens.
Interactions Overview
Which drug combinations should trigger pharmacist intervention?
There are few classic CYP-mediated interactions with misoprostol, but clinical interactions are important.
- Concurrent uterotonics such as oxytocin, dinoprostone or carboprost increase uterine activity and require close monitoring when used together.
- Combination NSAID formulations with misoprostol exist (for example Oxaprost) and are intended to reduce NSAID-related gastric injury; check prescription intent carefully.
- Drugs that worsen diarrhoea or hypotension can magnify misoprostol side effects; counsel accordingly.
Practical Canadian point: use provincial e-prescribing platforms and pharmacy systems to flag interactions, especially in older patients on anticoagulants or cardiovascular medicines.
Lifestyle: advise patients that heavy alcohol intake may worsen GI side effects and to stay hydrated if diarrhoea occurs.
Cultural Perceptions And Patient Habits
How do Canadian patients talk about misoprostol and abortion care?
Many patients prioritise privacy, clear bilingual information and non‑judgemental access to care.
Stigma around abortion persists in some regions and can deter help-seeking in rural and remote communities.
Telemedicine and pharmacy-based prescribing have improved access for Indigenous and northern communities but raise concerns about timely emergency backup when needed.
- Common patient concerns include privacy, side effects, and the need for follow-up support.
- Clinicians and pharmacists should offer bilingual counselling materials and culturally safe approaches for Indigenous patients.
| Access Factor | Urban | Rural/Remote |
|---|---|---|
| On-site Early Pregnancy Services | More available | Less available; relies on telemedicine |
| Emergency Backup | Closer and faster | Farther away; requires clear transfer agreements |
Funding expectation: patients expect low-cost or publicly covered services but provincial formularies differ, so verify coverage with Ontario Drug Benefit, BC PharmaCare or RAMQ when relevant.
Availability And Pricing Patterns
Can Canadians get misoprostol easily and affordably?
Availability is driven by Health Canada approvals, DIN listings and provincial procurement decisions.
Mifepristone/misoprostol combination products have been scaled into sexual health services in Canada, while standalone misoprostol brands may be inconsistently stocked.
| Region | Typical Price Pattern | Notes |
|---|---|---|
| Canada | Variable by province and public coverage | Check DIN and provincial formularies; chain availability varies |
| United States (Cross-Border) | Sometimes cheaper out-of-pocket | Cross-border purchasing raises legal and quality risks |
Online purchase rules in Canada require licensed suppliers and verification of prescriptions.
Data highlights: cross-border buying is common among uninsured travellers but carries customs and quality risks; Health Canada recommends checking DINs and supplier licences.
Supply-chain note: store below 25°C, protect from humidity and use climate-controlled transport for remote clinics.
Purchase context: In our online pharmacy, misoprostol is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Comparable Medicines And Preferences
What are the clinical alternatives to misoprostol and when are they preferred?
| Drug | Typical Use | Pros | Cons |
|---|---|---|---|
| Mifepristone | Medical abortion (in combination) | Improves effectiveness of misoprostol-based regimens | Requires prescription and regulated dispensing |
| Oxytocin | First-line uterotonic for active PPH in hospitals | Rapid IV/IM action in controlled settings | Requires parenteral administration and monitoring |
| Carboprost | Refractory PPH (injectable) | Effective when oxytocin fails | Contraindicated in asthma; parenteral use |
| Dinoprostone | Labour induction, PPH management | Uterotonic prostaglandin option | Availability and preference vary by institution |
Decision factors include efficacy, route, adverse‑event profile and availability on provincial formularies.
From a pharmacy perspective, ensure DIN checks when substituting brands and consult formularies for cost-preferred agents.
Patient-centred choices: in remote settings oral misoprostol may be chosen for PPH when IV oxytocin is not available, with clear emergency plans.
FAQ Section
Is misoprostol legal and available in Canada?
Yes, misoprostol is prescription-only and available through regulated channels.
Are misoprostol or mifepristone/misoprostol products integrated into Canadian practice?
Yes, mifepristone/misoprostol combinations are used in Canadian medical abortion programmes and appear on many provincial sexual health formularies; check DIN listings for brand-specific details.
Can I get misoprostol at local chains such as Shoppers or Rexall?
Availability varies by store and province; call ahead as provincial funding and local stock differ.
What side effects should I expect?
Common side effects include diarrhoea, abdominal pain and nausea, with more significant events such as heavy bleeding or fever requiring urgent assessment.
Is telemedicine an option for medical abortion in Canada?
Many provinces permit telemedicine prescribing and remote follow-up for medical abortion; remote clinics should have clear emergency transfer plans.
Can I cross the border to buy cheaper misoprostol tablets?
Cross-border purchase happens but raises legal, customs and quality concerns; verify DIN-equivalent products and supplier licences to reduce risk.
Emergency warning signs to emphasise to patients:
- Soaking more than two sanitary pads per hour for two hours;
- Syncope or fainting, severe dizziness, high fever >38°C with abdominal pain;
- Signs of severe allergic reaction such as difficulty breathing or swelling.
Guidelines For Proper Use
What should pharmacists do at dispensing and counselling to keep care safe?
Verify indication, route and timing against Health Canada guidance and local hospital protocols before release.
Confirm informed consent and screen for ectopic pregnancy where relevant.
Storage: store tablets below 25°C in a dry place and protect them from moisture.
Documentation: record DIN, batch number and lot on the dispensing record when available.
- Pharmacist Counselling Checklist:
- Confirm pregnancy test status and dates of last menstrual period.
- Explain dosing steps and administration route clearly, with bilingual materials where required.
- Advise on antiemetic or antidiarrhoeal options and when to seek emergency care.
- For remote dispensing, ensure transfer agreements with the nearest emergency facility are in place.
| Emergency Threshold | Action |
|---|---|
| Soaking >2 pads/hr | Seek emergency care immediately |
| High fever >38°C with abdominal pain | Attend urgent assessment |
| Syncope or severe dizziness | Call emergency services |
Provincial tips: reference Ontario Drug Benefit, BC PharmaCare and RAMQ for coverage questions and liaise with major chains for bilingual patient leaflets.
Adopt trauma-informed counselling approaches during reproductive care and provide written instructions in both official languages where needed.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-9 days |
| Hamilton | Ontario | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
